Search Results

There are 16190 results for: content related to: Tocilizumab as monotherapy or in combination with nonbiologic disease-modifying antirheumatic drugs: Twenty-four–week results of an open-label, clinical practice study

  1. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  2. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  3. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  4. You have free access to this content
    Poster Presentation Abstracts

    International Journal of Rheumatic Diseases

    Volume 19, Issue S2, September 2016, Pages: 21–293,

    Version of Record online : 19 SEP 2016, DOI: 10.1111/1756-185X.12962

  5. You have free access to this content
    ABSTRACTS – Online Panel Discussion (i-Pos)

    International Journal of Rheumatic Diseases

    Volume 11, Issue s1, September 2008, Pages: A84–A514,

    Version of Record online : 31 AUG 2008, DOI: 10.1111/j.1479-8077.2008.00373.x

  6. You have free access to this content
    Abstracts

    International Journal of Rheumatic Diseases

    Volume 18, Issue S1, September 2015, Pages: 4–138,

    Version of Record online : 2 SEP 2015, DOI: 10.1111/1756-185X.12730

  7. You have free access to this content
    Patients' Considerations in the Decision-Making Process of Initiating Disease-Modifying Antirheumatic Drugs

    Arthritis Care & Research

    Volume 67, Issue 7, July 2015, Pages: 956–964, Ingrid Nota, Constance H. C. Drossaert, Erik Taal and Mart A. F. J. van de Laar

    Version of Record online : 25 JUN 2015, DOI: 10.1002/acr.22531

  8. Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme?

    Internal Medicine Journal

    Volume 37, Issue 9, September 2007, Pages: 601–606, C. Y. Lu, K. M. Williams and R. O. Day

    Version of Record online : 2 JUN 2007, DOI: 10.1111/j.1445-5994.2007.01396.x

  9. You have free access to this content
    ACR/ARHP scientific abstracts

    Arthritis & Rheumatism

    Volume 42, Issue S9, September 1999, Pages: S71–S407,

    Version of Record online : 9 MAY 2012, DOI: 10.1002/art.1780422107

  10. You have free access to this content
    Tocilizumab — IL-6 inhibition for the treatment of rheumatoid arthritis

    Future Prescriber

    Volume 10, Issue 1, January 2009, Pages: 5–10, Professor Paul Emery and Rhonda Siddall

    Version of Record online : 26 FEB 2009, DOI: 10.1002/fps.41

  11. You have free access to this content
    Coverage for High-Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D

    Arthritis & Rheumatology

    Volume 67, Issue 6, June 2015, Pages: 1474–1480, Jinoos Yazdany, R. Adams Dudley, Randi Chen, Grace A. Lin and Chien-Wen Tseng

    Version of Record online : 25 MAY 2015, DOI: 10.1002/art.39079

  12. Evaluation of safety, efficacy and post-cessation efficacy durability of tocilizumab in patients with active rheumatoid arthritis

    International Journal of Rheumatic Diseases

    Arman Ahmadzadeh, Alireza N. Farahmand and Latif Gachkar

    Version of Record online : 19 SEP 2015, DOI: 10.1111/1756-185X.12686

  13. You have free access to this content
    Use and Spending for Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries

    Arthritis Care & Research

    Volume 67, Issue 9, September 2015, Pages: 1210–1218, Jinoos Yazdany, Chris Tonner and Gabriela Schmajuk

    Version of Record online : 26 AUG 2015, DOI: 10.1002/acr.22580

  14. You have free access to this content
    Abstracts

    Internal Medicine Journal

    Volume 45, Issue S2, May 2015, Pages: 1–46,

    Version of Record online : 10 MAY 2015, DOI: 10.1111/imj.12752

  15. You have free access to this content
    Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year

    Arthritis & Rheumatism

    Volume 63, Issue 3, March 2011, Pages: 609–621, Joel M. Kremer, Ricardo Blanco, Marek Brzosko, Ruben Burgos-Vargas, Anne-Marie Halland, Emma Vernon, Petra Ambs and Roy Fleischmann

    Version of Record online : 25 FEB 2011, DOI: 10.1002/art.30158

  16. You have free access to this content
    Rheumatoid Arthritis, Anti–Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative

    Arthritis & Rheumatology

    Volume 67, Issue 9, September 2015, Pages: 2311–2322, Rachel H. Mackey, Lewis H. Kuller, Kevin D. Deane, Brian T. Walitt, Yue-Fang Chang, V. Michael Holers, William H. Robinson, Russell P. Tracy, Mark A. Hlatky, Charles B. Eaton, Simin Liu, Matthew S. Freiberg, Mehret Birru Talabi, Erik B. Schelbert and Larry W. Moreland

    Version of Record online : 26 AUG 2015, DOI: 10.1002/art.39198

  17. You have full text access to this OnlineOpen article
    Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis

    Arthritis Care & Research

    Volume 67, Issue 10, October 2015, Pages: 1354–1362, Atsushi Ogata, Tatsuya Atsumi, Takaaki Fukuda, Yasuhiko Hirabayashi, Masaaki Inaba, Naoki Ishiguro, Motokazu Kai, Daisuke Kawabata, Daihei Kida, Hitoshi Kohsaka, Ryutaro Matsumura, Seiji Minota, Masaya Mukai, Takayuki Sumida, Kiyoshi Takasugi, Shigenori Tamaki, Tsutomu Takeuchi, Atsuhisa Ueda, Kazuhiko Yamamoto, Hisashi Yamanaka, Hajime Yoshifuji, Akira Nomura and the Musashi Study Investigators

    Version of Record online : 22 SEP 2015, DOI: 10.1002/acr.22598

  18. INFECTION-RELATED RHEUMATIC DISEASES

    APLAR Journal of Rheumatology

    Volume 9, Issue s1, August 2006, Pages: A80–A83,

    Version of Record online : 6 JUL 2006, DOI: 10.1111/j.1479-8077.2006.00199_14.x

  19. CELL RECEPTOR-LIGAND INTERACTION, SIGNALING AND ACTIVATION

    APLAR Journal of Rheumatology

    Volume 9, Issue s1, August 2006, Page: A39,

    Version of Record online : 6 JUL 2006, DOI: 10.1111/j.1479-8077.2006.00199_6.x

  20. RHEUMATOID ARTHRITIS – CLINICAL ASPECTS

    APLAR Journal of Rheumatology

    Volume 9, Issue s1, August 2006, Pages: A167–A188,

    Version of Record online : 6 JUL 2006, DOI: 10.1111/j.1479-8077.2006.00199_23.x